BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22307955)

  • 1. A concise total synthesis of deoxyschizandrin and exploration of its antiproliferative effects and those of structurally related derivatives.
    Zheng S; Aves SJ; Laraia L; Galloway WR; Pike KG; Wu W; Spring DR
    Chemistry; 2012 Mar; 18(11):3193-8. PubMed ID: 22307955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of Schizandrin derivatives as tubulin polymerization inhibitors.
    Dileep Kumar G; Siva B; Bharathi K; Devi A; Pavan Kumar P; Anusha K; Lambhate S; Karunakar T; Kumar Tiwari A; Suresh Babu K
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127354. PubMed ID: 32631552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and MDR inhibitory activity evaluation of derivatives of schizandrin A.
    Liang XX; Liu GT; Chen QH; Sun H; Chen DL; Wang FP
    J Asian Nat Prod Res; 2010 Jul; 12(7):549-56. PubMed ID: 20628932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
    Amujuri D; Siva B; Poornima B; Sirisha K; Sarma AVS; Lakshma Nayak V; Tiwari AK; Purushotham U; Suresh Babu K
    Eur J Med Chem; 2018 Apr; 149():182-192. PubMed ID: 29501940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Gomisin B analogues as potential cytotoxic agents: Design, synthesis, biological evaluation and docking studies.
    Poornima B; Siva B; Venkanna A; Shankaraiah G; Jain N; Yadav DK; Misra S; Babu KS
    Eur J Med Chem; 2017 Oct; 139():441-453. PubMed ID: 28818768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxyschizandrin, Isolated from Schisandra Berries, Induces Cell Cycle Arrest in Ovarian Cancer Cells and Inhibits the Protumoural Activation of Tumour-Associated Macrophages.
    Lee K; Ahn JH; Lee KT; Jang DS; Choi JH
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of Wuweizisu C and analogs.
    Chang JB; Wang Q; Li YF
    Curr Top Med Chem; 2009; 9(17):1660-75. PubMed ID: 19903156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong inhibition of deoxyschizandrin and schisantherin A toward UDP-glucuronosyltransferase (UGT) 1A3 indicating UGT inhibition-based herb–drug interaction.
    Liu C; Cao YF; Fang ZZ; Zhang YY; Hu CM; Sun XY; Huang T; Zeng J; Fan XR; Mo H
    Fitoterapia; 2012 Dec; 83(8):1415-9. PubMed ID: 23339253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive dibenzocyclooctadiene lignans from the stems of Schisandra neglecta.
    Gao XM; Wang RR; Niu DY; Meng CY; Yang LM; Zheng YT; Yang GY; Hu QF; Sun HD; Xiao WL
    J Nat Prod; 2013 Jun; 76(6):1052-7. PubMed ID: 23738539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2.
    Yoo HH; Lee M; Lee MW; Lim SY; Shin J; Kim DH
    Planta Med; 2007 May; 73(5):444-50. PubMed ID: 17566147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Total synthesis of schizandrin, the main active ingredient isolated from the Chinese herbal medicine fructus schizandrae].
    Chang J; Xie J
    Yao Xue Xue Bao; 1998 Jun; 33(6):424-8. PubMed ID: 12016911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition and cell cycle arrest in the G0/G1 by schizandrin, a dibenzocyclooctadiene lignan isolated from Schisandra chinensis, on T47D human breast cancer cells.
    Kim SJ; Min HY; Lee EJ; Kim YS; Bae K; Kang SS; Lee SK
    Phytother Res; 2010 Feb; 24(2):193-7. PubMed ID: 19585470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
    Slanina J; Páchniková G; Carnecká M; Porubová Koubíková L; Adámková L; Humpa O; Smejkal K; Slaninová I
    J Nat Prod; 2014 Oct; 77(10):2255-63. PubMed ID: 25302569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship study of cytotoxic neolignan derivatives using multivariate analysis and computation-aided drug design.
    de Sousa FS; Baldim JL; Azevedo RA; Figueiredo CR; Pieper P; Sear CE; Anderson EA; Lago JHG
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127349. PubMed ID: 32631547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of antiproliferative effects induced by Schisandra-derived dibenzocyclooctadiene lignans (+)-deoxyschisandrin and (-)-gomisin N in human tumour cell lines.
    Casarin E; Dall'Acqua S; Smejkal K; Slapetová T; Innocenti G; Carrara M
    Fitoterapia; 2014 Oct; 98():241-7. PubMed ID: 25110194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schisanhenol derivatives and their biological evaluation against tobacco mosaic virus (TMV).
    Wang QY; Deng LL; Liu JJ; Zhang JX; Hao XJ; Mu SZ
    Fitoterapia; 2015 Mar; 101():117-24. PubMed ID: 25598185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total synthesis of (+)-isoschizandrin utilizing a samarium(II) iodide-promoted 8-endo ketyl-olefin cyclization.
    Molander GA; George KM; Monovich LG
    J Org Chem; 2003 Dec; 68(25):9533-40. PubMed ID: 14656077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors.
    Xu L; Grandi N; Del Vecchio C; Mandas D; Corona A; Piano D; Esposito F; Parolin C; Tramontano E
    J Microbiol; 2015 Apr; 53(4):288-93. PubMed ID: 25740376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivatives of schisandrin with increased inhibitory potential on prostaglandin E(2) and leukotriene B(4) formation in vitro.
    Blunder M; Pferschy-Wenzig EM; Fabian WM; Hüfner A; Kunert O; Saf R; Schühly W; Bauer R
    Bioorg Med Chem; 2010 Apr; 18(7):2809-15. PubMed ID: 20236826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
    Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
    Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.